{"id":"https://openalex.org/W7225147828","doi":"https://doi.org/10.1158/1535-7163.mct-25-1542","title":"Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.","display_name":"Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225147828","doi":"https://doi.org/10.1158/1535-7163.mct-25-1542","pmid":"https://pubmed.ncbi.nlm.nih.gov/42975088"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-25-1542","doi":"https://doi.org/10.1158/1535-7163.mct-25-1542","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-25-1542","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038420682","display_name":"Filippo Spriano","orcid":"https://orcid.org/0000-0002-8615-1568","observed_orcids":["https://orcid.org/0000-0002-8615-1568"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Filippo Spriano","raw_affiliation_strings":["Institute of Oncology Research 1 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0002-8615-1568","affiliations":[{"raw_affiliation_string":"Institute of Oncology Research 1 Bellinzona","institution_ids":["https://openalex.org/I4210101830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012537023","display_name":"Luciano Cascione","orcid":"https://orcid.org/0000-0002-4606-0637","observed_orcids":["https://orcid.org/0000-0002-4606-0637"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Luciano Cascione","raw_affiliation_strings":["IOR - Institute of Oncology Research 2 Bellinzona, Ticino"],"raw_orcid":"https://orcid.org/0000-0002-4606-0637","affiliations":[{"raw_affiliation_string":"IOR - Institute of Oncology Research 2 Bellinzona, Ticino","institution_ids":["https://openalex.org/I4210101830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052684973","display_name":"Jacopo Sgrignani","orcid":"https://orcid.org/0000-0002-8633-1032","observed_orcids":["https://orcid.org/0000-0002-8633-1032"]},"institutions":[{"id":"https://openalex.org/I4210122345","display_name":"Institute for Research in Biomedicine","ror":"https://ror.org/01z1gye03","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122345","https://openalex.org/I4210132884","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jacopo Sgrignani","raw_affiliation_strings":["Institute for Research in Biomedicine 3"],"raw_orcid":"https://orcid.org/0000-0002-8633-1032","affiliations":[{"raw_affiliation_string":"Institute for Research in Biomedicine 3","institution_ids":["https://openalex.org/I4210122345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093742912","display_name":"Nikolai Bendik","orcid":"https://orcid.org/0009-0000-7580-4538","observed_orcids":["https://orcid.org/0009-0000-7580-4538"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Nikolai Bendik","raw_affiliation_strings":["Institute of Oncology Research 1 Bellinzona"],"raw_orcid":"https://orcid.org/0009-0000-7580-4538","affiliations":[{"raw_affiliation_string":"Institute of Oncology Research 1 Bellinzona","institution_ids":["https://openalex.org/I4210101830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114179501","display_name":"Alex Zadro","orcid":"https://orcid.org/0009-0003-1322-891X","observed_orcids":["https://orcid.org/0009-0003-1322-891X"]},"institutions":[{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alex Zadro","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana 4 Bellinzona"],"raw_orcid":"https://orcid.org/0009-0003-1322-891X","affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana 4 Bellinzona","institution_ids":["https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073945848","display_name":"Sara Napoli","orcid":"https://orcid.org/0000-0002-9699-7540","observed_orcids":["https://orcid.org/0000-0002-9699-7540"]},"institutions":[{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sara Napoli","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana 4 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0002-9699-7540","affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana 4 Bellinzona","institution_ids":["https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047236032","display_name":"Giulio Sartori","orcid":"https://orcid.org/0000-0001-6704-9755","observed_orcids":["https://orcid.org/0000-0001-6704-9755"]},"institutions":[{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Giulio Sartori","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana 4 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0001-6704-9755","affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana 4 Bellinzona","institution_ids":["https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059426213","display_name":"Concetta Guerra","orcid":"https://orcid.org/0000-0001-5597-6885","observed_orcids":["https://orcid.org/0000-0001-5597-6885"]},"institutions":[{"id":"https://openalex.org/I4210122345","display_name":"Institute for Research in Biomedicine","ror":"https://ror.org/01z1gye03","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122345","https://openalex.org/I4210132884","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Concetta Guerra","raw_affiliation_strings":["Institute for Research in Biomedicine 3"],"raw_orcid":"https://orcid.org/0000-0001-5597-6885","affiliations":[{"raw_affiliation_string":"Institute for Research in Biomedicine 3","institution_ids":["https://openalex.org/I4210122345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041093024","display_name":"Eleonora Cannas","orcid":"https://orcid.org/0009-0000-9551-7122","observed_orcids":["https://orcid.org/0009-0000-9551-7122"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Eleonora Cannas","raw_affiliation_strings":["Institute of Oncology Research 1 Bellinzona"],"raw_orcid":"https://orcid.org/0009-0000-9551-7122","affiliations":[{"raw_affiliation_string":"Institute of Oncology Research 1 Bellinzona","institution_ids":["https://openalex.org/I4210101830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063027086","display_name":"Tao Gong","orcid":"https://orcid.org/0000-0002-9414-6902","observed_orcids":["https://orcid.org/0000-0002-9414-6902"]},"institutions":[{"id":"https://openalex.org/I4387152247","display_name":"Institute for Research in Biomedicine","ror":"https://ror.org/05gfswd81","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4387152247","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Tao Gong","raw_affiliation_strings":["Institute for Research in Biomedicine 5 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0002-9414-6902","affiliations":[{"raw_affiliation_string":"Institute for Research in Biomedicine 5 Bellinzona","institution_ids":["https://openalex.org/I4387152247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007167867","display_name":"Alberto J. Arribas","orcid":"https://orcid.org/0000-0003-3123-6203","observed_orcids":["https://orcid.org/0000-0003-3123-6203","https://orcid.org/0000-0003-4971-9780"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alberto J. Arribas","raw_affiliation_strings":["Institute of Oncology Research 1 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0003-3123-6203","affiliations":[{"raw_affiliation_string":"Institute of Oncology Research 1 Bellinzona","institution_ids":["https://openalex.org/I4210101830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081278891","display_name":"Marco Pizzi","orcid":"https://orcid.org/0000-0003-4006-7317","observed_orcids":["https://orcid.org/0000-0003-4006-7317"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Pizzi","raw_affiliation_strings":["University of Padua 6 Padova"],"raw_orcid":"https://orcid.org/0000-0003-4006-7317","affiliations":[{"raw_affiliation_string":"University of Padua 6 Padova","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021133318","display_name":"David W. Scott","orcid":"https://orcid.org/0000-0002-0435-5947","observed_orcids":["https://orcid.org/0000-0002-0435-5947"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David W. Scott","raw_affiliation_strings":["British Columbia Cancer Agency 7 Vancouver"],"raw_orcid":"https://orcid.org/0000-0002-0435-5947","affiliations":[{"raw_affiliation_string":"British Columbia Cancer Agency 7 Vancouver","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002340499","display_name":"Matteo Moretti","orcid":"https://orcid.org/0000-0002-7301-1208","observed_orcids":["https://orcid.org/0000-0002-7301-1208","https://orcid.org/0000-0001-5637-8983"]},"institutions":[{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matteo Moretti","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana 4 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0002-7301-1208","affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana 4 Bellinzona","institution_ids":["https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015790909","display_name":"Davide Rossi","orcid":"https://orcid.org/0000-0002-2837-1597","observed_orcids":["https://orcid.org/0000-0002-2837-1597"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Davide Rossi","raw_affiliation_strings":["Oncology Institute of Southern Switzerland; Institute of Oncology Research 8 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0002-2837-1597","affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland; Institute of Oncology Research 8 Bellinzona","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027633474","display_name":"Davide F. Robbiani","orcid":"https://orcid.org/0000-0001-7379-3484","observed_orcids":["https://orcid.org/0000-0001-7379-3484"]},"institutions":[{"id":"https://openalex.org/I4210122345","display_name":"Institute for Research in Biomedicine","ror":"https://ror.org/01z1gye03","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122345","https://openalex.org/I4210132884","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Davide F. Robbiani","raw_affiliation_strings":["Institute for Research in Biomedicine 3"],"raw_orcid":"https://orcid.org/0000-0001-7379-3484","affiliations":[{"raw_affiliation_string":"Institute for Research in Biomedicine 3","institution_ids":["https://openalex.org/I4210122345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021953983","display_name":"Andrea Cavalli","orcid":"https://orcid.org/0000-0002-6370-1176","observed_orcids":["https://orcid.org/0000-0002-6370-1176","https://orcid.org/0000-0003-4063-4502"]},"institutions":[{"id":"https://openalex.org/I30771326","display_name":"Italian Institute of Technology","ror":"https://ror.org/042t93s57","country_code":"IT","type":"facility","lineage":["https://openalex.org/I30771326"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Cavalli","raw_affiliation_strings":["Italian Institute of Technology 9 Genoa, GE"],"raw_orcid":"https://orcid.org/0000-0003-4063-4502","affiliations":[{"raw_affiliation_string":"Italian Institute of Technology 9 Genoa, GE","institution_ids":["https://openalex.org/I30771326"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066518317","display_name":"Francesco Bertoni","orcid":"https://orcid.org/0000-0001-5637-8983","observed_orcids":["https://orcid.org/0000-0001-5637-8983","https://orcid.org/0000-0002-7301-1208"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Francesco Bertoni","raw_affiliation_strings":["Institute of Oncology Research 1 Bellinzona"],"raw_orcid":"https://orcid.org/0000-0001-5637-8983","affiliations":[{"raw_affiliation_string":"Institute of Oncology Research 1 Bellinzona","institution_ids":["https://openalex.org/I4210101830"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5038420682"],"corresponding_institution_ids":["https://openalex.org/I4210101830"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85956361,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.2831999957561493,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-endogenous-retrovirus-k","display_name":"HERV-K","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hml-2","display_name":"HML-2","score":0.8980000019073486},{"id":"https://openalex.org/keywords/envelope-protein","display_name":"envelope protein","score":0.6060000061988831},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/endogenous-retroviruses","display_name":"endogenous retroviruses","score":0.8650000095367432},{"id":"https://openalex.org/keywords/transposable-elements","display_name":"transposable elements","score":0.9629999995231628},{"id":"https://openalex.org/keywords/immunotherapy-targets","display_name":"immunotherapy targets","score":0.5580000281333923},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.7850000262260437},{"id":"https://openalex.org/keywords/nanobodies","display_name":"nanobodies","score":0.6069999933242798},{"id":"https://openalex.org/keywords/heavy-chain-antibodies","display_name":"heavy-chain antibodies","score":0.6159999966621399},{"id":"https://openalex.org/keywords/antigen-uptake","display_name":"antigen uptake","score":0.6990000009536743},{"id":"https://openalex.org/keywords/interferon-signaling","display_name":"interferon signaling","score":0.5920000076293945},{"id":"https://openalex.org/keywords/viral-mimicry","display_name":"viral mimicry","score":0.7200000286102295},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.7045999765396118},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6564000248908997},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.5679000020027161},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5536999702453613},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5238999724388123},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5023999810218811},{"id":"https://openalex.org/C121346293","wikidata":"https://www.wikidata.org/wiki/Q1340715","display_name":"Endogenous retrovirus","level":4,"score":0.47690001130104065},{"id":"https://openalex.org/C166342232","wikidata":"https://www.wikidata.org/wiki/Q11936831","display_name":"Minigene","level":5,"score":0.4562000036239624},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.4242999851703644},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.4171999990940094},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4108000099658966},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40610000491142273},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.40459999442100525},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4034000039100647},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36010000109672546},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3547999858856201},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3490000069141388},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34790000319480896},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.3424000144004822},{"id":"https://openalex.org/C2778431562","wikidata":"https://www.wikidata.org/wiki/Q189308","display_name":"Retrovirus","level":3,"score":0.3330000042915344},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.31779998540878296},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.3046000003814697},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2955000102519989},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2824999988079071},{"id":"https://openalex.org/C2777257650","wikidata":"https://www.wikidata.org/wiki/Q4833719","display_name":"B-cell lymphoma","level":3,"score":0.2791000008583069},{"id":"https://openalex.org/C47289529","wikidata":"https://www.wikidata.org/wiki/Q908550","display_name":"Open reading frame","level":4,"score":0.27619999647140503},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.27090001106262207},{"id":"https://openalex.org/C2777589544","wikidata":"https://www.wikidata.org/wiki/Q7667896","display_name":"T-cell lymphoma","level":3,"score":0.26269999146461487},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.257099986076355},{"id":"https://openalex.org/C2781241564","wikidata":"https://www.wikidata.org/wiki/Q1347450","display_name":"Epitope mapping","level":4,"score":0.2547999918460846},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.25429999828338623},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25360000133514404}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-25-1542","doi":"https://doi.org/10.1158/1535-7163.mct-25-1542","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-25-1542","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:42975088","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42975088","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393087449","https://openalex.org/W4391006063","https://openalex.org/W4389056972","https://openalex.org/W4230244087","https://openalex.org/W4388048525","https://openalex.org/W4210712743","https://openalex.org/W1517242930","https://openalex.org/W2034728978","https://openalex.org/W2085353600","https://openalex.org/W2793184824"],"abstract_inverted_index":{"PURPOSE:":[0],"Human":[1],"endogenous":[2,9],"retrovirus":[3,10],"K":[4],"(HERV-K/HML-2)":[5],"is":[6,19],"a":[7,46,72,174,220],"human-specific":[8],"family":[11],"that":[12],"maintains":[13],"intact":[14],"open":[15],"reading":[16],"frames":[17],"and":[18,43,56,71,78,93,112,116,126,134,146,162,165,201,205,218,237],"aberrantly":[20],"expressed":[21],"in":[22,61,86,110,159,180,197],"multiple":[23],"cancers.":[24],"We":[25],"tested":[26,127],"whether":[27],"HERV-K,":[28],"specifically":[29],"its":[30],"envelope":[31],"(Env)":[32],"protein,":[33],"marks":[34],"clinically":[35,143],"relevant":[36],"diffuse":[37],"large":[38],"B-cell":[39],"lymphoma":[40,87,177],"(DLBCL)":[41],"states":[42,217],"serves":[44],"as":[45],"tractable":[47],"immunotherapeutic":[48],"target.":[49],"EXPERIMENTAL":[50],"DESIGN:":[51],"Locus-level":[52],"transposable":[53],"element":[54],"(TE)":[55],"HERV":[57],"expression":[58,80,149],"was":[59,84,98,157,168],"quantified":[60],"two":[62],"independent":[63],"DLBCL":[64,141,216],"RNA-seq":[65],"cohorts":[66],"using":[67,90],"curated":[68],"TE":[69,138],"annotation":[70],"uniform":[73],"alignment/counting":[74],"workflow.":[75],"Env":[76,102,155,182],"transcript":[77],"protein":[79,167],"(including":[81],"cell-surface":[82],"localization)":[83],"validated":[85],"cell":[88,163,178],"lines":[89],"RT-qPCR,":[91],"immunoblotting,":[92],"flow":[94],"cytometry.":[95],"Functional":[96],"relevance":[97],"assessed":[99],"by":[100],"siRNA-mediated":[101],"knockdown.":[103],"Candidate":[104],"extracellular":[105],"linear":[106],"epitopes":[107],"were":[108,123],"predicted":[109],"silico":[111],"synthesized":[113],"for":[114,128,229],"serological":[115],"phage":[117],"display":[118],"assays.":[119],"Anti-Env":[120],"camelid":[121],"VHHs":[122],"isolated,":[124],"humanized,":[125],"binding,":[129],"antibody-dependent":[130],"cellular":[131],"cytotoxicity":[132],"(ADCC),":[133],"antigen-dependent":[135,208],"internalization.":[136,209],"RESULTS:":[137],"transcripts":[139],"stratified":[140],"into":[142],"distinct":[144],"subgroups,":[145],"high":[147],"HERV-K":[148,211,233],"associated":[150],"with":[151],"an":[152],"interferon/viral-mimicry":[153],"program.":[154],"RNA":[156],"detected":[158,169],"patient":[160],"tumors":[161],"lines,":[164,179],"the":[166,171],"on":[170],"surface":[172,192,222],"of":[173,176,227],"subset":[175],"which":[181],"knockdown":[183],"reduced":[184],"proliferation.":[185],"A":[186],"humanized":[187],"heavy-chain":[188],"antibody":[189],"(FF-01)":[190],"bound":[191],"Env,":[193,234],"induced":[194],"selective":[195],"ADCC":[196],"Env-positive":[198],"models":[199],"(reporter":[200],"primary":[202],"NK-cell":[203],"assays),":[204],"underwent":[206],"rapid":[207],"CONCLUSIONS:":[210],"activity":[212],"identifies":[213],"biologically":[214],"meaningful":[215],"exposes":[219],"targetable":[221],"antigen.":[223],"FF-01":[224],"provides":[225],"proof":[226],"principle":[228],"antibody-based":[230],"strategies":[231],"against":[232],"including":[235],"ADCC-":[236],"ADC-oriented":[238],"approaches.":[239]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}